Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/11/1998 | US5792609 Nucleotide fragment used to distinguish types of malaria from one another by hybridizing to dna sample |
08/11/1998 | US5792607 Specific hybridization of probe/primer end so that the probability of the probe/primer contributing to spurious signal development is greatly reduced |
08/11/1998 | US5792604 Introducing antigen into donor cell, incubating with primed cytotoxic t lymphocytes, measuring detectable marker released into medium |
08/11/1998 | US5792467 Repellent compositions containing aromatic aldehydes |
08/11/1998 | US5792463 Hybrid particle immunogens |
08/11/1998 | US5792462 Alphavirus RNA replicon systems |
08/11/1998 | US5792459 HIV-1 envelope muteins lacking hypervariable domains |
08/11/1998 | US5792456 Mutant BR96 antibodies reactive with human carcinomas |
08/11/1998 | US5792453 Transfecting cells in coronary arteries by injection of a transgene-inserted replication-deficit adenovirus; antiischemic agents; cardiotonic agents; vascular disease |
08/11/1998 | CA1339992C Anticoagulant polypeptede |
08/11/1998 | CA1339991C Replicative rna-based amplification/detection system |
08/10/1998 | CA2223008A1 Def1 |
08/10/1998 | CA2222998A1 Def2 |
08/07/1998 | CA2228816A1 Ferulic acid decarboxylase |
08/07/1998 | CA2222987A1 Novel compounds |
08/07/1998 | CA2222984A1 Novel rat |
08/07/1998 | CA2222978A1 Novel compounds |
08/07/1998 | CA2222961A1 Novel compounds |
08/07/1998 | CA2222957A1 Novel histidine kinase |
08/06/1998 | WO1998034121A2 Isolated p27 protein and methods for its production and use |
08/06/1998 | WO1998034120A1 Protein fragment complementation assays to detect biomolecular interactions |
08/06/1998 | WO1998034110A1 In situ identification of target structures e.g. in vivo selection method for a phage library |
08/06/1998 | WO1998033942A1 Diagnosis and treatment of myocardial failure |
08/06/1998 | WO1998033932A1 Lipid emulsions as gene transfection agents and method of preparing said emulsions |
08/06/1998 | WO1998033930A1 A method for the production of dicarboxylic acids |
08/06/1998 | WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses |
08/06/1998 | WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
08/06/1998 | WO1998033927A1 Genetically transformed plants demonstrating resistance to porphyrinogen biosynthesis-inhibiting herbicides |
08/06/1998 | WO1998033926A1 Reagents and methods useful for detecting diseases of the lung |
08/06/1998 | WO1998033925A1 Glutrnagln amidotransferase - a novel essential translational component |
08/06/1998 | WO1998033924A1 O-fucosyltransferase |
08/06/1998 | WO1998033922A1 The neurotrophic factor nnt-1 |
08/06/1998 | WO1998033921A1 Novel human cystatin-like protein |
08/06/1998 | WO1998033920A2 Tissue factor pathway inhibitor-3 |
08/06/1998 | WO1998033919A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
08/06/1998 | WO1998033918A1 Morphogenic proteins |
08/06/1998 | WO1998033917A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
08/06/1998 | WO1998033916A2 Secreted proteins and polynucleotides encoding them |
08/06/1998 | WO1998033915A1 Breast cancer specific gene 1 |
08/06/1998 | WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
08/06/1998 | WO1998033913A1 Human integral membrane protein |
08/06/1998 | WO1998033912A1 MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE |
08/06/1998 | WO1998033911A1 Human signal transduction protein regulating the nuclear movement |
08/06/1998 | WO1998033910A1 Novel proline-rich membrane protein |
08/06/1998 | WO1998033909A1 Novel human atpase inhibitor protein |
08/06/1998 | WO1998033908A1 Human c5a-like receptor |
08/06/1998 | WO1998033907A1 A tumor suppressor designated ts10q23.3 |
08/06/1998 | WO1998033906A1 Insecticidal gene and peptide |
08/06/1998 | WO1998033905A1 K-atp channels, materials and methods relating to cell membrane proteins |
08/06/1998 | WO1998033904A2 An antisense oligonucleotide preparation method |
08/06/1998 | WO1998033903A1 Tissue specific promoters |
08/06/1998 | WO1998033901A2 Generation of diversity in combinatorial libraries |
08/06/1998 | WO1998033900A1 Method and apparatus for predicting protein function site, method for improving protein function, and function-improved protein |
08/06/1998 | WO1998033899A1 Knockout animals |
08/06/1998 | WO1998033896A2 Microorganisms with increased production of clavulanic acid |
08/06/1998 | WO1998033895A1 A thermostable endo-beta-1,4-glucanase |
08/06/1998 | WO1998033893A2 Ribozymes cleaving epidermal growth factor receptors |
08/06/1998 | WO1998033891A1 Method for the production of selected lymphocytes |
08/06/1998 | WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |
08/06/1998 | WO1998033887A1 Growth differentiation factor-8 |
08/06/1998 | WO1998033884A1 Renibacterium salmoninarum vaccine |
08/06/1998 | WO1998033819A1 Cellular receptors for subgroup c adenoviruses and group b coxsackieviruses |
08/06/1998 | WO1998033818A1 Human anion channel |
08/06/1998 | WO1998033817A1 Human membrane protein |
08/06/1998 | WO1998033816A1 Nucleic acid encoding an acetyl-coenzyme-a transporter protein |
08/06/1998 | WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof) |
08/06/1998 | WO1998033808A2 A reversible stoichiometric process for conjugating biomolecules |
08/06/1998 | WO1998033807A1 Anti-viral guanosine-rich tetrad forming oligonucleotides |
08/06/1998 | WO1998033529A1 Treatment for urinary incontinence using gene therapy techniques |
08/06/1998 | WO1998033527A2 Cancer immunotherapy with semi-allogeneic cells |
08/06/1998 | WO1998033519A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
08/06/1998 | WO1998033518A1 Mutants of thymidylate synthase and uses thereof |
08/06/1998 | WO1998033513A1 Soluble ctla4 mutant molecules and uses thereof |
08/06/1998 | WO1998033510A1 Restenosis/atherosclerosis diagnosis, prophylaxis and therapy |
08/06/1998 | WO1998033509A2 Useful properties of human lactoferrin and variants thereof |
08/06/1998 | WO1998033478A2 Rna- and dna-based active agents in nanoparticles |
08/06/1998 | WO1998033387A1 Tolerance to natural antibody antigens |
08/06/1998 | WO1998033379A1 A novel method for treating epidermal or dermal conditions |
08/06/1998 | WO1998027116A3 Protein binding fragments of gravin |
08/06/1998 | WO1998024906A3 Isolated mammalian monocyte cell genes; related reagents |
08/06/1998 | WO1998024813A3 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
08/06/1998 | WO1998022587A3 Pituitary-tumor-transforming-genes, and related products |
08/06/1998 | WO1998021332A3 Secreted proteins and polynucleotides encoding them |
08/06/1998 | WO1998020034A3 Novel serine protease inhibitor nucleic acid molecules, proteins and uses thereof |
08/06/1998 | WO1998017317A3 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
08/06/1998 | WO1998016645A3 Compounds and methods for diagnosis of tuberculosis |
08/06/1998 | CA2284463A1 A reversible stoichiometric process for conjugating biomolecules |
08/06/1998 | CA2280229A1 Breast cancer specific gene 1 |
08/06/1998 | CA2279991A1 Human anion channel |
08/06/1998 | CA2279579A1 Insecticidal gene and peptide |
08/06/1998 | CA2279577A1 Treatment for urinary incontinence using gene therapy techniques |
08/06/1998 | CA2279552A1 Tissue specific promoters |
08/06/1998 | CA2279551A1 Reagents and methods useful for detecting diseases of the lung |
08/06/1998 | CA2279548A1 Ribozymes cleaving epidermal growth factor receptors |
08/06/1998 | CA2279547A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
08/06/1998 | CA2279542A1 Tolerance to natural antibody antigens |
08/06/1998 | CA2279490A1 Glutrnagln amidotransferase - a novel essential translational component |
08/06/1998 | CA2279488A1 Anti-viral guanosine-rich tetrad forming oligonucleotides |
08/06/1998 | CA2279487A1 Knockout animals |
08/06/1998 | CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use |